Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Basket Trial of Intraperitoneal Paclitaxel Plus Systemic Therapy in Gastrointestinal Malignancies With Peritoneal Carcinomatosis (STOPGAP - B)

NCT07795749 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT07795749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Basket Trial of Intraperitoneal Paclitaxel Plus Systemic Therapy in Gastrointestinal Malignancies With Peritoneal Carcinomatosis (STOPGAP - B)
Lead sponsor
University of California, Irvine
Phase
Phase 2
Overall status
Recruiting
Start date
August 4, 2026
Completion date
August 31, 2029
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendiceal adenocarcinoma, colorectal adenocarcinoma, esophageal carcinoma, gastric cancer (diagnosis), hepatobiliary carcinoma in situ, small bowel adenocarcinoma